Peterson, Alexander A. http://orcid.org/0000-0001-7674-9980
Rangwala, Aziz M. http://orcid.org/0000-0003-3556-7931
Thakur, Manish K.
Ward, Patrick S. http://orcid.org/0000-0001-6437-8174
Hung, Christie http://orcid.org/0000-0001-9311-9542
Outhwaite, Ian R. http://orcid.org/0000-0003-2037-3261
Chan, Alix I. http://orcid.org/0000-0002-2698-4031
Usanov, Dmitry L. http://orcid.org/0000-0003-3030-2918
Mootha, Vamsi K.
Seeliger, Markus A. http://orcid.org/0000-0003-0990-1756
Liu, David R. http://orcid.org/0000-0002-9943-7557
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM118062)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01 EB022376)
Howard Hughes Medical Institute (Liu investigatorship)
Article History
Received: 19 January 2022
Accepted: 19 July 2022
First Online: 26 September 2022
Competing interests
: A.A.P. and D.R.L. are co-inventors on patent applications that are based on this work. D.R.L. is a consultant and co-founder of Exo Therapeutics, a company that uses DNA-encoded libraries and exo-site inhibition.